lactose has been researched along with prednisolone in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Inouye, K; Machida, Y; Nagai, T | 1 |
| Buchanan, WW; Downie, WW; Jasani, MK; Samuels, BM | 1 |
| Epstein, SW; Fletcher, CM; Oppenheimer, EA | 1 |
| Fassihi, R; Kim, H | 2 |
| Haslam, JL; Rao, VM; Stella, VJ | 1 |
| Haslam, JL; Sotthivirat, S; Stella, VJ | 1 |
| Cen, YY; Chen, YD; Han, MG; Li, SJ; Liang, ZY; Tian, YQ; Yang, DS; Zhang, H; Zhang, J | 1 |
| Ahmed, W; Alhnan, MA; Arafat, B; Isreb, A; Kelarakis, A; Sadia, M; Sośnicka, A | 1 |
| Fukuda, T; Ikeuchi-Takahashi, Y; Takami, K; Yamatani, A | 1 |
1 trial(s) available for lactose and prednisolone
| Article | Year |
|---|---|
Ibuprofen in rheumatoid arthritis. Clinical study of analgesic and anti-inflammatory activity.
Topics: Adult; Aged; Alanine Transaminase; Arthritis, Rheumatoid; Aspartate Aminotransferases; Aspirin; Double-Blind Method; Female; Humans; Ibuprofen; Lactose; Male; Middle Aged; Pain; Prednisolone | 1968 |
10 other study(ies) available for lactose and prednisolone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Sustained release tablets based on chitosan and carboxymethylcellulose sodium.
Topics: Carboxymethylcellulose Sodium; Chemistry, Pharmaceutical; Chitin; Chitosan; Delayed-Action Preparations; Lactose; Methylcellulose; Prednisolone; Solubility; Tablets | 1987 |
Daily peak flow measurements in the assessment of steroid therapy for airway obstruction.
Topics: Adult; Aged; Bronchodilator Agents; Dyspnea; Female; Humans; Lactose; Male; Middle Aged; Placebos; Prednisolone; Respiratory Tract Diseases; Spirometry | 1969 |
Application of a binary polymer system in drug release rate modulation. 1. Characterization of release mechanism.
Topics: Delayed-Action Preparations; Gels; Hydrogen-Ion Concentration; Kinetics; Lactose; Methylcellulose; Oxazines; Pectins; Prednisolone; Pressure; Tablets; Viscosity | 1997 |
Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics.
Topics: Delayed-Action Preparations; Diltiazem; Kinetics; Lactose; Methylcellulose; Molecular Weight; Nifedipine; Oxazines; Pectins; Prednisolone; Pressure; Solubility; Tablets; Theophylline | 1997 |
Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE)(7m)-beta-cyclodextrin as a solubilizing agent.
Topics: beta-Cyclodextrins; Cyclodextrins; Lactose; Methylcellulose; Oxazines; Prednisolone; Solubility; Tablets; X-Ray Diffraction | 2001 |
Controlled porosity-osmotic pump pellets of a poorly water-soluble drug using sulfobutylether-beta-cyclodextrin, (SBE) 7M-beta-CD, as a solubilizing and osmotic agent.
Topics: Anti-Inflammatory Agents; beta-Cyclodextrins; Chemistry, Pharmaceutical; Diffusion; Excipients; Freeze Drying; Lactose; Osmosis; Pharmaceutical Preparations; Porosity; Prednisolone; Sodium Chloride; Solubility; Spectrophotometry, Ultraviolet; Urea | 2007 |
Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma.
Topics: Administration, Oral; Anti-Inflammatory Agents; Asthma; Carboxymethylcellulose Sodium; Cellulose; Chemistry, Pharmaceutical; Chitosan; Drug Delivery Systems; Drug Liberation; Excipients; Hardness; Humans; Hydrogen-Ion Concentration; Lactose; Nanoparticles; Prednisolone; Solubility; Tablets | 2015 |
Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets.
Topics: Calcium Phosphates; Captopril; Cellulose; Drug Compounding; Drug Liberation; Excipients; Humans; Lactose; Mesalamine; Polymethacrylic Acids; Prednisolone; Printing, Three-Dimensional; Tablets; Talc; Theophylline | 2016 |
Effect of Diluents on Active Pharmaceutical Ingredient Loss Until Patients Ingest Powder Formulation.
Topics: Chemistry, Pharmaceutical; Drug Compounding; Excipients; Humans; Lactose; Particle Size; Powders; Prednisolone | 2023 |